BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21253393)

  • 1. T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients.
    Szczepanik AM; Siedlar M; Sierzega M; Goroszeniuk D; Bukowska-Strakova K; Czupryna A; Kulig J
    World J Gastroenterol; 2011 Jan; 17(3):343-8. PubMed ID: 21253393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
    He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
    Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma.
    Cheng HH; Tseng GY; Yang HB; Wang HJ; Lin HJ; Wang WC
    World J Gastroenterol; 2012 Jan; 18(1):34-43. PubMed ID: 22228968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant peripheral blood CD4
    Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
    Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.
    Yuan XL; Chen L; Zhang TT; Ma YH; Zhou YL; Zhao Y; Wang WW; Dong P; Yu L; Zhang YY; Shen LS
    World J Gastroenterol; 2011 Apr; 17(15):2019-27. PubMed ID: 21528082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD4+CD25+ regulatory T cells and Foxp3 in peripheral blood of patients with gastric carcinoma.
    Chen SL; Cai SR; Zhang XH; Peng JJ; Li WF; Zhai ET; Chen JH; Wu H; Chen CQ; Ma JP; He YL
    J Biol Regul Homeost Agents; 2016; 30(1):197-204. PubMed ID: 27049092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
    Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
    Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3 expression in CD4
    Zhu XW; Zhu HZ; Zhu YQ; Feng MH; Qi J; Chen ZF
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):677-682. PubMed ID: 27752897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling pathway regulates CD4
    Yang L; Zhao KL; Qin L; Ji DX; Zhang B; Zheng PF; Qin YM
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy.
    Stelmaszczyk-Emmel A; Zawadzka-Krajewska A; Szypowska A; Kulus M; Demkow U
    Int Arch Allergy Immunol; 2013; 162(1):16-24. PubMed ID: 23817221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.
    Xu WH; Zhang AM; Ren MS; Zhang XD; Wang F; Xu XC; Li Q; Wang J; Din BS; Wu YB; Chen GH
    J Clin Immunol; 2012 Oct; 32(5):975-83. PubMed ID: 22467037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified flow cytometry method for objective estimation of human CD4
    Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
    Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, frequency, activation and function of CD4+ CD25(high)FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis.
    Stelmaszczyk-Emmel A; Jackowska T; Rutkowska-Sak L; Marusak-Banacka M; Wąsik M
    Rheumatol Int; 2012 May; 32(5):1147-54. PubMed ID: 21249500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping of Human Regulatory T Cells.
    Staats J
    Methods Mol Biol; 2019; 2032():141-177. PubMed ID: 31522418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
    Wei HG; Cai B; Wang LL; Li J; Feng WH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.